Analytical Science

Digesting regulatory guidance is not always easy, but understanding the main points – and then paying attention to the details – will improve your chances of success.

Can R&D organizations really afford to kill off analytical data that could be used for future decision-making?

In-depth analysis of original and new candidate drugs for biosimilars is easier than ever before…

New technologies for extractables and leachables testing of small molecules and biopharmaceuticals.

Starting a bioanalytical research company after years working for Big Pharma has been daunting…

More quality control testing is needed to ensure that antibiotics don't become targets for fraudsters.

Continuous monitoring of pharma products with an innovative matchbox-sized laser

Lawrence (Larry) Lesko is a bioanalytical veteran with many years of academic and FDA experience under his belt.

Manufacturing is getting smarter; only a cross-discipline approach will ensure the success of tomorrow’s processes.

A promising new process – dropwise additive manufacturing of pharmaceutical products (DAMPP) – brings medicine production down to size.